3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Diseases
1
Pain
1
Leiomyoma
1
Inflammation
1
Hyperuricemia
1
Gout
1
Dysmenorrhea
1
Cardiovascular Diseases
1
Arthritis
1
Interventions
ulipristal acetate
9
Leuprolide
4
Uterine Artery Embolization
3
ulipristal
2
Tranexamic Acid
2
Letrozole
2
Bupivacaine
2
ferrous sulfate
1
elagolix
1
dienogest
1
cetrorelix
1
Vitamin B 6
1
Uterine Myomectomy
1
Sodium Chloride
1
Sirolimus
1
Saline Solution
1
Rocuronium
1
Pregabalin
1
Oxytocin
1
Naproxen
1
Misoprostol
1
Mifepristone
1
Lidocaine
1
Ibuprofen
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
DMAC2L protein, human
1
Celecoxib
1
Anesthetics, Local
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Leiomyoma
×
Naproxen
×
Clear all
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled